Biotech stocks poised for a comeback as interest rates fall
Rate cuts are on the horizon, and it’s the moment biotech companies and their investors have been eagerly anticipating. Biotech stocks have struggled to deliver the kind of returns typically associated with the “tech” in their name. The SPDR S&P Biotech ETF (XBI) has only achieved a 4.6% annualised return over the past five years, […]
Biotech stocks poised for a comeback as interest rates fall Read More »